Arrivent BioPharma, Inc. (AVBP)
29.79
-0.49
(-1.62%)
USD |
NASDAQ |
Sep 09, 16:00
29.84
+0.06
(+0.18%)
After-Hours: 20:00
Arrivent BioPharma Price to Book Value : 3.924 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 3.924 |
| September 08, 2026 | 3.988 |
| September 04, 2026 | 4.077 |
| September 03, 2026 | 4.087 |
| September 02, 2026 | 4.019 |
| September 01, 2026 | 3.971 |
| August 31, 2026 | 3.958 |
| August 28, 2026 | 3.974 |
| August 27, 2026 | 4.083 |
| August 26, 2026 | 4.102 |
| August 25, 2026 | 4.129 |
| August 24, 2026 | 3.722 |
| August 21, 2026 | 3.836 |
| August 20, 2026 | 3.844 |
| August 19, 2026 | 3.954 |
| August 18, 2026 | 3.952 |
| August 17, 2026 | 3.821 |
| August 14, 2026 | 3.887 |
| August 13, 2026 | 3.952 |
| August 12, 2026 | 4.144 |
| August 11, 2026 | 4.135 |
| August 10, 2026 | 4.082 |
| August 07, 2026 | 4.062 |
| August 06, 2026 | 4.085 |
| August 05, 2026 | 4.032 |
| Date | Value |
|---|---|
| August 04, 2026 | 4.148 |
| August 03, 2026 | 3.904 |
| July 31, 2026 | 3.928 |
| July 30, 2026 | 4.038 |
| July 29, 2026 | 3.957 |
| July 28, 2026 | 3.949 |
| July 27, 2026 | 3.973 |
| July 24, 2026 | 4.179 |
| July 23, 2026 | 4.154 |
| July 22, 2026 | 4.010 |
| July 21, 2026 | 3.722 |
| July 20, 2026 | 3.717 |
| July 17, 2026 | 4.372 |
| July 16, 2026 | 4.315 |
| July 15, 2026 | 4.340 |
| July 14, 2026 | 4.286 |
| July 13, 2026 | 4.431 |
| July 10, 2026 | 4.438 |
| July 09, 2026 | 4.435 |
| July 08, 2026 | 4.399 |
| July 07, 2026 | 4.502 |
| July 06, 2026 | 4.543 |
| July 02, 2026 | 4.567 |
| July 01, 2026 | 4.544 |
| June 30, 2026 | 4.576 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cytokinetics, Inc. | -- |
| Gilead Sciences, Inc. | 15.28 |
| Ionis Pharmaceuticals, Inc. | 21.10 |
| Vertex Pharmaceuticals, Inc. | 6.520 |
| ACADIA Pharmaceuticals, Inc. | 3.647 |
Price to Book Value Related Metrics
| Price | 29.79 |
| Earnings Yield | -12.36% |
| Market Cap | 1.439B |